Data on this page show the responses of individuals who identify as Aboriginal and Torres Strait Islander who received a Shingrix® vaccine and completed an AusVaxSafety survey sent on day 3 after vaccination. These data give a profile of what to expect in the days following  Shingrix® vaccination and can assist when planning for your Shingrix® vaccination. Data on this page are updated monthly.

AusVaxSafety's active vaccine safety surveillance system complements the enhanced safety surveillance activities of the Therapeutic Goods Administration (TGA). Find out more about how the TGA monitors the safety of COVID-19 vaccines and how you can report side effects on the TGA website.

Last updated May 2024